Experienced in Nonalcoholic Steatohepatitis (NASH)

Dr. Donald L. Zogg

Gastroenterology
5705 W Old Shakopee Rd, 
Bloomington, MN 
Experienced in Nonalcoholic Steatohepatitis (NASH)
5705 W Old Shakopee Rd, 
Bloomington, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Donald Zogg is a Gastroenterologist in Bloomington, Minnesota. Dr. Zogg is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Alcoholic Cirrhosis, Ascites, Visceromegaly, Endoscopy, and Gastrectomy.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Nonalcoholic Steatohepatitis (NASH).

Specialties
Gastroenterology
Licenses
Internal Medicine in MN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

5705 W Old Shakopee Rd, Bloomington, MN 55437

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

2 Total Publications

The Cost of Complications Following Major Resection of Malignant Neoplasia.
The Cost of Complications Following Major Resection of Malignant Neoplasia.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: March 17, 2018
Similar Doctors
Distinguished in Nonalcoholic Steatohepatitis (NASH)
Dr. Ibrahim Hanouneh
Gastroenterology
Distinguished in Nonalcoholic Steatohepatitis (NASH)
Dr. Ibrahim Hanouneh
Gastroenterology

Mngi Digestive Health PA

1185 Town Centre Dr, Suite 205, 
Eagan, MN 
 (10.2 miles away)
612-871-1145
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ibrahim Hanouneh is a Gastroenterologist in Eagan, Minnesota. Dr. Hanouneh is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Hepatitis, Ascites, Cirrhosis, Liver Transplant, and Endoscopy.

Advanced in Nonalcoholic Steatohepatitis (NASH)
Dr. Thomas Leventhal
Gastroenterology
Advanced in Nonalcoholic Steatohepatitis (NASH)
Dr. Thomas Leventhal
Gastroenterology

U Of M Health Clinics And Surgery Center Inc.

909 Fulton St SE, 
Minneapolis, MN 
 (13.0 miles away)
612-672-7422
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Leventhal is a Gastroenterologist in Minneapolis, Minnesota. Dr. Leventhal is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Gastrostomy.

Advanced in Nonalcoholic Steatohepatitis (NASH)
Dr. Anupama U. Nookala
Gastroenterology
Advanced in Nonalcoholic Steatohepatitis (NASH)
Dr. Anupama U. Nookala
Gastroenterology

Group Health Plan Inc

401 Phalen Blvd, 
Saint Paul, MN 
 (17.2 miles away)
651-254-7400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anupama Nookala is a Gastroenterologist in Saint Paul, Minnesota. Dr. Nookala is rated as an Advanced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). Her top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Alcoholic Cirrhosis, Hepatitis, Endoscopy, and Colonoscopy. Dr. Nookala is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zogg's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile